Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan flag Japan · Delayed Price · Currency is JPY
888.00
-9.00 (-1.00%)
Nov 18, 2026, 10:30 AM JST

TYO:4570 Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,0821,004969816794647
Revenue Growth
7.13%3.61%18.75%2.77%22.72%7.47%
Cost of Revenue
302298335300268271
Gross Profit
780706634516526376
Selling, General & Admin
317299300282289310
Research & Development
120120119129179188
Operating Expenses
443425425406474498
Operating Income
33728120911052-122
Interest Expense
-1-1-1-1-1-
Interest & Investment Income
21--1-
Earnings From Equity Investments
-----203-152
Currency Exchange Gain (Loss)
56-3843
Other Non Operating Income (Expenses)
1414571228
EBT Excluding Unusual Items
357301210124-135-243
Gain (Loss) on Sale of Investments
-11----130-
Asset Writedown
-----14-7
Other Unusual Items
-----1-
Pretax Income
346301210124-280-250
Income Tax Expense
-28-28-39-6298
Net Income
374329249186-289-258
Net Income to Common
374329249186-289-258
Net Income Growth
17.24%32.13%33.87%---
Shares Outstanding (Basic)
999999
Shares Outstanding (Diluted)
999999
Shares Change
------
EPS (Basic)
40.1635.3326.7419.97-31.03-27.70
EPS (Diluted)
40.1635.3326.7419.97-31.03-27.70
EPS Growth
17.24%32.13%33.87%---

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
28726812411726-93
Free Cash Flow Per Share
30.8228.7813.3112.562.79-9.99
Dividend Per Share
6.0006.000----
Dividend Growth
------
Gross Margin
72.09%70.32%65.43%63.23%66.25%58.11%
Operating Margin
31.15%27.99%21.57%13.48%6.55%-18.86%
Profit Margin
34.57%32.77%25.70%22.79%-36.40%-39.88%
Free Cash Flow Margin
26.52%26.69%12.80%14.34%3.28%-14.37%
EBITDA
356299224112--
EBITDA Margin
32.90%29.78%23.12%13.73%--
D&A For EBITDA
1918152--
EBIT
33728120911052-122
EBIT Margin
31.15%27.99%21.57%13.48%6.55%-18.86%